These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 21441785)
1. 6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland. Beck A; Wurch T; Reichert JM MAbs; 2011; 3(2):111-32. PubMed ID: 21441785 [TBL] [Abstract][Full Text] [Related]
2. 4th European Antibody Congress 2008: December 1-3, 2008, Geneva, Switzerland. Beck A; Hanala S; Reichert JM MAbs; 2009; 1(2):93-103. PubMed ID: 20061813 [TBL] [Abstract][Full Text] [Related]
3. Keystone Symposium on Antibodies as Drugs: March 27-April 1, 2009, Whistler, BC CA. Wurch T; Larbouret C; Robert B MAbs; 2009; 1(4):318-25. PubMed ID: 20068403 [TBL] [Abstract][Full Text] [Related]
4. 8(th) Annual European Antibody Congress 2012: November 27-28, 2012, Geneva, Switzerland. Beck A; Carter PJ; Gerber HP; Lugovskoy AA; Wurch T; Junutula JR; Kontermann RE; Mabry R MAbs; 2013; 5(3):339-57. PubMed ID: 23493119 [TBL] [Abstract][Full Text] [Related]
5. 7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland. Lugovskoy AA; Reichert JM; Beck A MAbs; 2012; 4(2):134-52. PubMed ID: 22453093 [TBL] [Abstract][Full Text] [Related]
7. Fourth World Antibody-Drug Conjugate Summit: February 29-March 1, 2012, Frankfurt, Germany. Beck A; Lambert J; Sun M; Lin K MAbs; 2012; 4(6):637-47. PubMed ID: 22909934 [TBL] [Abstract][Full Text] [Related]
8. World Antibody-Drug Conjugate Summit, October 15-16, 2013, San Francisco, CA. Klinguer-Hamour C; Strop P; Shah DK; Ducry L; Xu A; Beck A MAbs; 2014; 6(1):18-29. PubMed ID: 24423618 [TBL] [Abstract][Full Text] [Related]
10. World Antibody Drug Conjugate Summit Europe: February 21-23, 2011; Frankfurt, Germany. Beck A; Senter P; Chari R MAbs; 2011; 3(4):331-7. PubMed ID: 21691144 [TBL] [Abstract][Full Text] [Related]
11. 5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland. Beck A; Reichert JM; Wurch T MAbs; 2010; 2(2):108-28. PubMed ID: 20179425 [No Abstract] [Full Text] [Related]
12. CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances. Newsome SD; Aliotta PJ; Bainbridge J; Bennett SE; Cutter G; Fenton K; Lublin F; Northrop D; Rintell D; Walker BD; Weigel M; Zackowski K; Jones DE Int J MS Care; 2016; 18(6):314-323. PubMed ID: 27999526 [TBL] [Abstract][Full Text] [Related]
13. Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition. Hidalgo-Mazzei D; Berk M; Cipriani A; Cleare AJ; Florio AD; Dietch D; Geddes JR; Goodwin GM; Grunze H; Hayes JF; Jones I; Kasper S; Macritchie K; McAllister-Williams RH; Morriss R; Nayrouz S; Pappa S; Soares JC; Smith DJ; Suppes T; Talbot P; Vieta E; Watson S; Yatham LN; Young AH; Stokes PRA Br J Psychiatry; 2019 Jan; 214(1):27-35. PubMed ID: 30520709 [TBL] [Abstract][Full Text] [Related]
14. World Bispecific Antibody Summit, September 27-28, 2011, Boston, MA. Dhimolea E; Reichert JM MAbs; 2012; 4(1):4-13. PubMed ID: 22327426 [TBL] [Abstract][Full Text] [Related]
16. IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA. Arnett SO; Teillaud JL; Wurch T; Reichert JM; Dunlop C; Huber M MAbs; 2011; 3(2):133-52. PubMed ID: 21304271 [TBL] [Abstract][Full Text] [Related]
18. Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples. Fabbri C; Kasper S; Kautzky A; Bartova L; Dold M; Zohar J; Souery D; Montgomery S; Albani D; Raimondi I; Dikeos D; Rujescu D; Uher R; Lewis CM; Mendlewicz J; Serretti A Br J Psychiatry; 2019 Jan; 214(1):36-41. PubMed ID: 30468137 [TBL] [Abstract][Full Text] [Related]
19. IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA. Marquardt J; Begent RH; Chester K; Huston JS; Bradbury A; Scott JK; Thorpe PE; Veldman T; Reichert JM; Weiner LM MAbs; 2012; 4(6):648-52. PubMed ID: 23007482 [TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects. Smith MR; Sandhu S; George DJ; Chi KN; Saad F; Thiery-Vuillemin A; Stàhl O; Olmos D; Danila DC; Gafanov R; Castro E; Moon H; Joshua AM; Mason GE; Espina BM; Liu Y; Lopez-Gitlitz A; Francis P; Bevans KB; Fizazi K J Manag Care Spec Pharm; 2023 Jul; 29(7):758-768. PubMed ID: 37404070 [No Abstract] [Full Text] [Related] [Next] [New Search]